Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,208.12 +80.43 (+7.13%)
Official Closing Price Updated: 7:00 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
News headline image
The Master Architect of Molecules: How Google DeepMind’s AlphaProteo is Rewriting the Blueprint for Cancer Therapy
In the quest to cure humanity’s most devastating diseases, the bottleneck has long been the "wet lab"—the arduous, years-long process of trial and error required to find a protein that can stick to a... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Eli Lilly Reinforces Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
In a decisive move to solidify its leadership in the next generation of chronic inflammation and cardiometabolic treatments, Eli Lilly and Company (NYSE: LLY) announced the acquisition of Ventyx... 
Via MarketMinute
News headline image
1 Pharmaceutical Stock Set to Rebound in 2026 ↗
Novo Nordisk stock will ride a wave of demand for Ozempic pills in 2026. 
Via The Motley Fool
Eli Lilly & Co (NYSE:LLY) Presents a Compelling Mix of Fundamental Growth and Technical Breakout Potential ↗
Via Chartmill
Novo Nordisk In Green After Oral Wegovy Clocks Over 18K Prescriptions In A Week ↗
Via Stocktwits
ELI LILLY & CO (NYSE:LLY) Offers a Durable Dividend with Strong Growth and Financial Health ↗
Via Chartmill
News headline image
Carvina Capital: Strong Demand Lifts Aktis IPO
Via AB Newswire
News headline image
Up 36%, Is Eli Lilly Still a Buy? ↗
Thanks to its weight loss and diabetes products, the drug company has seen its shares soar. 
Via The Motley Fool
News headline image
Where Will Eli Lilly Be in 10 Years? ↗
Eli Lilly is the leader in GLP-1 weight loss drugs today, but that advantage won't last forever. 
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
2 Profitable Stocks to Own for Decades and 1 Facing Headwinds
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
A Look Back at Pharmaceuticals Stocks’ Q3 Earnings: Ocular Therapeutix (NASDAQ:OCUL) Vs The Rest Of The Pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Ocular Therapeutix... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
The Silicon Laureates: How the 2024 Nobel Prizes Rewrote the Rules of Scientific Discovery
The year 2024 marked a historic inflection point in the history of science, as the Royal Swedish Academy of Sciences awarded Nobel Prizes in both Physics and Chemistry to pioneers of artificial... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker? ↗
Both companies may succeed in this industry. 
Via The Motley Fool
News headline image
A Look Into Eli Lilly and Co Inc&#39;s Price Over Earnings ↗
 
Via Benzinga
News headline image
The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
The biotechnology sector has always been a high-stakes arena where clinical success can create multi-billion-dollar empires overnight, and a failed negotiation can erase a fifth of a company’s market... 
Via Finterra
Topics Economy Initial Public Offering
News headline image
Prediction: This Healthcare Stock Could Soar by 40% in 2026 ↗
This pharmaceutical giant has recently caught fire, and the stock's run is likely just beginning. 
Via The Motley Fool
News headline image
My Top AI Healthcare Stock to Buy and Hold for 20 Years ↗
This drugmaker continues to strengthen its investment thesis. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
3 Mid-Cap Stocks with Open Questions
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
News headline image
3 Growth Stocks to Invest $1,000 in Right Now ↗
It comes as no surprise that all three of them are capitalizing on relatively new, but game-changing, developments. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Should You Dump Eli Lilly's Shares After This Setback? ↗
The company got some bad news to start 2026. 
Via The Motley Fool
News headline image
Google, Nvidia, Lilly Lead 5 Stocks Near Buy Points ↗
These trillion-dollar stocks may be setting up for their next move. 
Via Investor's Business Daily
News headline image
The $5 Trillion Renaissance: How 2025 Redefined Global Deal-Making
The global financial landscape has undergone a seismic shift as 2025 closed with merger and acquisition (M&A) volumes surpassing a staggering $5 trillion. This "M&A Renaissance" marks a definitive end... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? ↗
Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing. 
Via The Motley Fool
News headline image
Why a 15% Dividend Wasn’t Enough to Keep This $3.3 Million Position ↗
Trinity Capital provides venture debt and equipment financing to growth-stage tech companies seeking non-dilutive capital solutions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Outfront Media Surges 40% in One Year, Then Gets Cut Loose Despite 'Exceptional Performance' ↗
This out-of-home advertising REIT connects brands with urban audiences through a broad network of billboard and transit assets. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly
Date: January 23, 2026 Introduction In the high-stakes arena of metabolic medicine, few companies have generated as much speculative fervor and clinical awe as Viking Therapeutics (NASDAQ: VKTX). As of... 
Via Finterra
Topics Intellectual Property
News headline image
Oral Wegovy Is Off To An Astronomical Launch. Will It Save Novo Nordisk Stock? ↗
Novo Nordisk stock rose Friday on report its oral Wegovy clocked 18,000 prescriptions in its second week on the market. 
Via Investor's Business Daily
News headline image
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗
This biotech has candidates in late-stage clinical development. 
Via The Motley Fool
News headline image
2 Mega-Cap Stocks to Target This Week and 1 We Find Risky
Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing... 
Via StockStory
News headline image
The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era
Eli Lilly (NYSE: LLY) has once again demonstrated its resilience and market-leading strength, logging a significant 5.2% gain over the last five trading days as of January 22, 2026. This recent rally... 
Via MarketMinute
Topics Economy
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.